A Pharmacovigilance Study from 2004 to 2024 Utilizing the FDA Adverse Event Reporting System (FAERS) Examines Ischemic Adverse Events Linked to Triptan Use in Migraine Therapy
Authors:
Posted in Papers / Human Studies|Original Research / October 16-31, 2025
J Pain Res. 2025 Oct 11;18:5331-5345. doi: 10.2147/JPR.S551333. eCollection 2025.
PMID: 41103977 | PMC: PMC12523564 | DOI: 10.2147/JPR.S551333
Share this article
Sign Up For An MSC Newsletter
Register to Watch the MSC Emerging Science Contest!
The MSC Emerging Science Contest for Young Investigators will take place on Wednesday, December 13, 2023, from 8-10 PM Eastern (US) time. We welcome those who wish to watch the event as an attendee. Register here to attend, and learn more about the contest here.